|
QUILT 3.076 phase 1 study of memory-like cytokine-enriched natural killer (M-CENK) cells plus N-803 in locally advanced or metastatic solid tumors. |
| |
|
Consulting or Advisory Role - Gilead Sciences; Gilead Sciences; Lilly; Menarini; Novartis; regeneron; Sanofi; Stemline Therapeutics |
Speakers' Bureau - Gilead Sciences; Merck; Novartis; Regeneron; Sanofi |
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Regeneron; Sanofi |
| |
|
Employment - Chan Soon-Shiong Institute for Advanced Health; Hoag |
Consulting or Advisory Role - Bayer; ipsen |
| |
|
Employment - Chan Soon-Shiong Institute for Medicine |
Stock and Other Ownership Interests - ImmunityBio |
Travel, Accommodations, Expenses - Chan Soon-Shiong Institute for Medicine |
| |
|
|
Stock and Other Ownership Interests - ImmunityBio |
| |
|
|
Stock and Other Ownership Interests - ImmunityBio Inc. |
Patents, Royalties, Other Intellectual Property - Pat App 63/558,017 |
| |
|
Employment - ImmunityBio Inc. |
Stock and Other Ownership Interests - ImmunityBio |
Patents, Royalties, Other Intellectual Property - Pat App 63/558,017 |
| |
|
|
Stock and Other Ownership Interests - ImmunityBio |
Patents, Royalties, Other Intellectual Property - Au2017264931A1; EP396444A4; JP2021001188A; US10947207B2; US11243215B2; US20190048012A1; Wo2017004436A2; Wo2017087685A1; Wo2018187240A1 |
| |
|
|
Stock and Other Ownership Interests - ImmunityBio |
| |
|
|
Stock and Other Ownership Interests - ImmunityBio |
| |
|
|
|
Stock and Other Ownership Interests - ImmunityBio |
Consulting or Advisory Role - Anthem Blue Cross Blue Shield |
| |
|
No Relationships to Disclose |
| |
|
|
Leadership - ImmunityBio; NantHealth |
Stock and Other Ownership Interests - ImmunityBio; NantHealth |
Patents, Royalties, Other Intellectual Property - Patents held in ImmunityBio, NantHealth, NANT IP Holdings, and NantWorks & Affiliates |